References
Arama E,
Dickman D,
Kimchie Z,
Shearn A and
Lev Z
(2000)
Mutations in the beta‐propeller domain of the Drosophila brain tumor (brat) protein induce neoplasm in the larval brain.
Oncogene
19:
3706–3716.
Awasaki T,
Lai SL,
Ito K and
Lee T
(2008)
Organization and postembryonic development of glial cells in the adult central brain of Drosophila.
Journal of Neuroscience
28:
13742–13753.
Bainton RJ,
Tsai LT,
Schwabe T et al.
(2005)
Moody encodes two GPCRs that regulate cocaine behaviors and blood‐brain barrier permeability in Drosophila.
Cell
123:
145–156.
Beaucher M,
Goodliffe J,
Hersperger E et al.
(2007)
Drosophila brain tumor metastases express both neuronal and glial cell type markers.
Developmental Biology
301:
287–297.
Betschinger J,
Mechtler K and
Knoblich JA
(2006)
Asymmetric segregation of the tumor suppressor brat regulates self‐renewal in Drosophila neural stem cells.
Cell
124:
1241–1253.
Bier E
(2005)
Drosophila, the golden bug, emerges as a tool for human genetics.
Nature Reviews. Genetics
6:
9–23.
Bilen J and
Bonini NM
(2005)
Drosophila as a model for human neurodegenerative disease.
Annual Review of Genetics
39:
153–171.
Brand AH and
Perrimon N
(1993)
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.
Development
118:
401–415.
Brumby AM and
Richardson HE
(2005)
Using Drosophila melanogaster to map human cancer pathways.
Nature Reviews. Cancer
5:
626–639.
Dietzl G,
Chen D,
Schnorrer F et al.
(2007)
A genome‐wide transgenic RNAi library for conditional gene inactivation in Drosophila.
Nature
448:
151–156.
Doherty J,
Logan MA,
Tasdemir OE and
Freeman MR
(2009)
Ensheathing glia function as phagocytes in the adult Drosophila brain.
Journal of Neuroscience
29:
4768–4781.
Duffy JB
(2002)
GAL4 system in Drosophila: a fly geneticist's Swiss army knife.
Genesis
34:
1–15.
Endersby R and
Baker SJ
(2008)
PTEN signaling in brain: neuropathology and tumorigenesis.
Oncogene
27:
5416–5430.
Franzdottir SR,
Engelen D,
Yuva‐Aydemir Y et al.
(2009)
Switch in FGF signalling initiates glial differentiation in the Drosophila eye.
Nature
460:
758–761.
Furnari FB,
Fenton T,
Bachoo RM et al.
(2007)
Malignant astrocytic glioma: genetics, biology, and paths to treatment.
Genes & Development
21:
2683–2710.
Gateff E
(1978)
Malignant neoplasms of genetic origin in Drosophila melanogaster.
Science
200:
1448–1459.
Hamaratoglu F,
Willecke M,
Kango‐Singh M et al.
(2006)
The tumour‐suppressor genes NF2/Merlin and expanded act through Hippo signalling to regulate cell proliferation and apoptosis.
Nature Cell Biology
8:
27–36.
Holland EC,
Celestino J,
Dai C et al.
(2000)
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.
Nature Genetics
25:
55–57.
Jeibmann A and
Paulus W
(2009)
Drosophila melanogaster as a model organism of brain diseases.
International Journal of Molecular Sciences
10:
407–440.
Klambt C
(2009)
Modes and regulation of glial migration in vertebrates and invertebrates.
Nature Reviews. Neuroscience
10:
769–779.
Lai SL and
Lee T
(2006)
Genetic mosaic with dual binary transcriptional systems in Drosophila.
Nature Neuroscience
9:
703–709.
Lee T and
Luo L
(1999)
Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis.
Neuron
22:
451–461.
Li J,
Xia F and
Li WX
(2003)
Coactivation of STAT and Ras is required for germ cell proliferation and invasive migration in Drosophila.
Developmental Cell
5:
787–798.
Louis DN,
Ohgaki H,
Wiestler OD et al.
(2007)
The 2007 WHO classification of tumours of the central nervous system.
Acta Neuropathologica
114:
97–109.
McGuire SE,
Le PT,
Osborn AJ,
Matsumoto K and
Davis RL
(2003)
Spatiotemporal rescue of memory dysfunction in Drosophila.
Science
302:
1765–1768.
McGuire SE,
Mao Z and
Davis RL
(2004a)
Spatiotemporal gene expression targeting with the TARGET and gene‐switch systems in Drosophila.
Science's STKE: Signal Transduction Knowledge Environment
2004:
pl6.
McGuire SE,
Roman G and
Davis RL
(2004b)
Gene expression systems in Drosophila: a synthesis of time and space.
Trends in Genetics
20:
384–391.
Nicholson L,
Singh GK,
Osterwalder T et al.
(2008)
Spatial and temporal control of gene expression in Drosophila using the inducible GeneSwitch GAL4 system. I. Screen for larval nervous system drivers.
Genetics
178:
215–234.
Ohgaki H and
Kleihues P
(2005)
Epidemiology and etiology of gliomas.
Acta Neuropathologica
109:
93–108.
Omuro AM and
Delattre JY
(2008)
What is the place of bevacizumab and irinotecan in the treatment of glioblastoma and other malignant gliomas?
Current Opinion in Neurology
21:
717–719.
Read RD,
Cavenee WK,
Furnari FB and
Thomas JB
(2009)
A Drosophila model for EGFR‐Ras and PI3K‐dependent human glioma.
PLoS Genetics
5:
e1000374.
Read RD,
Goodfellow PJ,
Mardis ER et al.
(2005)
A Drosophila model of multiple endocrine neoplasia type 2.
Genetics
171:
1057–1081.
Schwabe T,
Bainton RJ,
Fetter RD,
Heberlein U and
Gaul U
(2005)
GPCR signaling is required for blood‐brain barrier formation in Drosophila.
Cell
123:
133–144.
Silies M,
Yuva Y,
Engelen D et al.
(2007)
Glial cell migration in the eye disc.
Journal of Neuroscience
27:
13130–13139.
Stork T,
Engelen D,
Krudewig A et al.
(2008)
Organization and function of the blood‐brain barrier in Drosophila.
Journal of Neuroscience
28:
587–597.
Stork T,
Thomas S,
Rodrigues F et al.
(2009)
Drosophila neurexin IV stabilizes neuron‐glia interactions at the CNS midline by binding to wrapper.
Development
136:
1251–1261.
Vidal M and
Cagan RL
(2006)
Drosophila models for cancer research.
Current Opinion in Genetics & Development
16:
10–16.
Wismar J,
Loffler T,
Habtemichael N et al.
(1995)
The Drosophila melanogaster tumor suppressor gene lethal(3)malignant brain tumor encodes a proline‐rich protein with a novel zinc finger.
Mechanics of Development
53:
141–154.
Witte HT,
Jeibmann A,
Klambt C and
Paulus W
(2009)
Modeling glioma growth and invasion in Drosophila melanogaster.
Neoplasia
11:
882–888.
Woodhouse E,
Hersperger E and
Shearn A
(1998)
Growth, metastasis, and invasiveness of Drosophila tumors caused by mutations in specific tumor suppressor genes.
Development Genes and Evolution
207:
542–550.
Zheng H,
Ying H,
Yan H et al.
(2008a)
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Nature
455:
1129–1133.
Zheng H,
Ying H,
Yan H et al.
(2008b)
Pten and p53 converge on c‐Myc to control differentiation, self‐renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
Cold Spring Harbor Symposia on Quantitative Biology
73:
427–437.